Yttrium 90 radioembolization: The horizon is changing for patients with intermediate and advanced hepatocellular carcinoma

Authors

  • Luigi Bolondi M.D.,

    Corresponding author
    1. Department of Digestive Diseases and Internal Medicine Policlinico S. Orsola Malpighi Bologna, Italy
    • Division of Internal Medicine, Department of Digestive Diseases and Internal Medicine, University of Bologna, Via Albertoni 15, Bologna 40138, Italy
    Search for more papers by this author
    • fax: +39-051-6362884

  • Fabio Piscaglia M.D., Ph.D.

    1. Department of Digestive Diseases and Internal Medicine Policlinico S. Orsola Malpighi Bologna, Italy
    Search for more papers by this author

  • See Article on Page 1826

  • Potential conflict of interest: Dr. Piscaglia consults for and is on the speakers' bureau of Bayer. He is also on the speakers' bureau of Siemens and Roche. He received grants from Bracco. Dr. Bolondi is on the speakers' bureau of Sirtex.

No abstract is available for this article.

Ancillary